Back to all AI Solutions
cNEURO cMRI
cMRI quantifies volumes and disease-specific scores from MR images of the brain. Results are contrasted with normative data and relevant results for different disease areas are summarized in reports. Healthcare benefits: Product increases quality of radiology reports and time-efficiency of doctors compared to when no decision support system is used.
Key benefits
- Disease-specific imaging biomarkers and clinical reports
- 99% robustness in T1 segmentation
- 100% workflow integration
Details
- Regulatory:
MRI
Brain
Neurology
CE
FDA
UKCA
CH
- Clinical Applications:
MRI
Brain
Neurology
CE
FDA
UKCA
CH
- Modality:
MRI
Brain
Neurology
CE
FDA
UKCA
CH
- Body Part:
MRI
Brain
Neurology
CE
FDA
UKCA
CH
Peer-reviewed publications
- Evaluating combinations of diagnostic tests to discriminate different dementia types. Read
- Automatically computed rating scales from MRI for patients with cognitive disorders. Read
- Detecting frontotemporal dementia syndromes using MRI biomarkers. Read
- Fast and robust multi-atlas segmentation of brain magnetic resonance images. Read
- Differential diagnosis of neurodegenerative diseases using structural MRI data. Read
